APAdchara Prommaban

Adchara Prommaban

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adchara Prommaban has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and Associated Factors of Dual Physical and Cognitive Impairment Among Adults Aged 50 Years and Older with Cardiometabolic Conditions: A Cross-Sectional Study

    by Kanokporn Pinyopornpanish, Suphawita Pliannuom, Peerasak Lerttrakarnnon, Sutina Laimangkorn, Pimchai Veerasirikul, Adchara Prommaban, Chaisiri Angkurawaranon

    Background: Dual impairment of physical and cognitive capacities is associated with adverse health outcomes in aging populations and may emerge during middle age. However, evidence on its prevalence and associated factors among adults with cardiometabolic conditions in primary care settings remains limited, particularly in Southeast Asia. This study aimed to determine the prevalence of dual impairment and identify factors associated with dual impairment among adults aged ≥50 years with cardiometabolic conditions. Methods: A cross-sectional study was conducted among adults aged ≥50 years who had at least one cardiometabolic condition and attended a primary care clinic at a university-affiliated health center in Northern Thailand between March 2024 and July 2025. Dual impairment was defined as impaired cognitive function, assessed using the Montreal Cognitive Assessment (MoCA), together with impaired physical function, defined as either slow gait speed or low handgrip strength. Multivariable logistic regression analysis was used to examine factors associated with dual impairment. Results: A total of 196 participants were included. The mean age was 69.08 ± 6.15 years, and 72.96% were female. The prevalence of dual impairment was 25.00%. In the primary fully adjusted model (Model 1), lower LDL-C was the only factor significantly associated with dual impairment (adjusted OR [aOR] = 0.98, 95% CI: 0.97–1.00, p = 0.021). In the secondary parsimonious model (Model 2), female sex was associated with higher odds of dual impairment (aOR = 2.48, 95% CI: 1.05–5.84, p = 0.038), whereas age was not statistically significant (aOR = 1.04, 95% CI: 0.99–1.10, p = 0.139). The inverse association between LDL-C and dual impairment remained significant in Model 2 (aOR = 0.98, 95% CI: 0.97–0.99, p = 0.020). Conclusions: Dual impairment was identified in approximately one-quarter of participants, representing a substantial burden among individuals with cardiometabolic conditions. The observed inverse association between LDL-C and dual impairment should be interpreted cautiously given the potential for reverse causation and residual confounding, as well as the lack of information on lipid-lowering medication use. The identified associations are exploratory and warrant confirmation in larger prospective multicenter studies.

  • Open Access

    The Effect of Exercise Program Interventions on Frailty, Clinical Outcomes, and Biomarkers in Older Adults: A Systematic Review

    by Adchara Prommaban, Sasiwimon Moonkayaow, Phichayut Phinyo, Penprapa Siviroj, Wachiranun Sirikul, Peerasak Lerttrakarnnon

    Background: Frailty is characterized by the decreased ability in older adults to handle daily or acute stressors due to age-related declines in physiological reserve and organ system performance. This condition results from the interaction of multiple physiological pathways and changes in biomarkers. Exercise programs are currently recommended to promote “healthy aging” in frail older adults. Objective: This systematic review aimed to evaluate the effectiveness of exercise program interventions in improving outcomes related to frailty, physical function, cognitive performance, and biomarkers in frail older adults. Methods: This study was designed according to the PRISMA guidelines. A systematic search was conducted in PubMed, Embase, and Scopus for studies published between 2014 and 2024. Two independent reviewers extracted data, with disagreements resolved by a third reviewer. Randomized controlled trials involving pre-frail or frail older adults aged 60 and above in all settings were included. The focus was on the impact of exercise programs, especially multicomponent interventions, on frailty outcomes and biomarkers. Results: Nine studies involving a total of 2083 participants met the inclusion criteria. The age range of participants was 65.35 ± 5.15 to 86.7 ± 4.00 years, with 64.7% being female. The results demonstrated that multicomponent exercise programs significantly improved frailty status, enhanced physical and cognitive function, and improved emotional well-being. Additionally, these programs led to significant reductions in inflammatory biomarkers, such as IL-6 and TNF-α, which are associated with frailty. Conclusion: This review highlights the beneficial effects of multicomponent exercise programs on pre-frail and frail older adults, providing evidence that these interventions improve physical and cognitive functions and emotional well-being, and reduce inflammation. These findings offer valuable insights into developing targeted interventions to manage frailty in clinical practice.


  • Open Access

    Comparison of Frailty Assessment Tools for Older Thai Individuals at the Out-Patient Clinic of the Family Medicine Department

    by Pimonpan Rattanapattanakul, Adchara Prommaban, Peerasak Lerttrakarnnon

    This study evaluated the validity of the screening tools used to evaluate the frailty status of older Thai people. A cross-sectional study of 251 patients aged 60 years or more in an out-patient department was conducted using the Frailty Assessment Tool of the Thai Ministry of Public Health (FATMPH) and the Frail Non-Disabled (FiND) questionnaire, and the results were compared with Fried’s Frailty Phenotype (FFP). The validity of the data acquired using each method was evaluated by examining their sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and Cohen’s kappa coefficient. Most of the participants were female (60.96%), and most were between 60 and 69 years old (65.34%). The measured prevalences of frailty were 8.37%, 17.53%, and 3.98% using FFP, FATMPH, and FiND tools, respectively. FATMP had a sensitivity of 57.14%, a specificity of 86.09%, a PPV of 27.27%, and an NPV of 95.65%. FiND had a sensitivity of 19.05%, a specificity of 97.39%, a PPV of 40.00%, and an NPV of 92.94%. The results of the Cohen’s kappa comparison of these two tools and FFP were 0.298 for FATMPH and 0.147 for FiND. The predictive values of both FATMPH and FiND were insufficient for assessing frailty in a clinical setting. Additional research on other frailty tools is necessary to improve the accuracy of frailty screening in the older population of Thailand.


  • Open Access

    Impact of Green Extraction on Curcuminoid Content, Antioxidant Activities and Anti-Cancer Efficiency (In Vitro) from Turmeric Rhizomes (Curcuma longa L.)

    by Kanjana Singh, Somdet Srichairatanakool, Teera Chewonarin, Adchara Prommaban, Rajnibhas Sukeaw Samakradhamrongthai, Margaret Anne Brennan, Charles Stephen Brennan, Niramon Utama-Ang

    Turmeric (Curcuma longa L.) powder is widely used as a spice and seasoning in Asian countries. This study investigated the effect of turmeric extracts on the anticancer activity of Huh7 and HCT 116 cells. The curcumin bioactive compounds were extracted using various methods such as microwave-assisted extraction (MAE), ultrasound-assisted extraction (UAE) and traditional extraction (TDE). The yield of dried extracts from MAE was found to be the highest at 17.89%, followed by UAE and TDE, with 11.34% and 5.54%, respectively. Antioxidant activities such as TPC, DPPH and FRAP from MAE were higher than those of UAE and TDE. The total curcuminoid contents from the novel extractions were higher than those from traditional extraction methods. For instance, curcuminoid contents from MAE, UAE and TDE were 326.79, 241.17 and 215.83 mg/g, respectively. Due to having the highest bioactive compounds and extraction yield, turmeric extract from MAE was used to investigate the potential anticancer properties. The extract showed significant cytotoxic potential against the human liver (Huh7) and human colon (HCT116) cell lines, in concentrations ranging from 31.25 to 1000.00 µg/mL. Turmeric extracts using MAE have potential anticancer effects on Huh7 and HCT116 cells. This study serves as scientific data for the chemotherapeutic properties of turmeric extracts and their use as functional ingredients.


  • Open Access

    Antioxidant Potential and Cytotoxic Effect of Isoflavones Extract from Thai Fermented Soybean (Thua-Nao)

    by Kanokwan Kulprachakarn, Supakit Chaipoot, Rewat Phongphisutthinant, Narisara Paradee, Adchara Prommaban, Sakaewan Ounjaijean, Kittipan Rerkasem, Wason Parklak, Kanittha Prakit, Banthita Saengsitthisak, et al.

    Thua-nao, or Thai fermented soybeans, is a traditional Lanna fermented food in Northern Thailand. It is produced by using a specific bacterial species called Bacillus subtilis var. Thua-nao. We investigated the antioxidant activity and cytotoxic effect of isoflavones from Thua-nao. The phenolic compound contents and total flavonoid contents were determined by spectrophotometry. The antioxidant activity was examined using the ABTS, FRAP, and DPPH assays. The isoflavone contents and phenolic compositions were examined by the high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) techniques. The ability of isoflavones to inhibit human cancer cell growth was assessed by the MTT assay. The total phenolic content, total flavonoid content, and antioxidant activities of the isoflavones were 49.00 ± 0.51 mg GAE/g of dry extract (DE), 10.76 ± 0.82 mg QE/g of DE, 61.03 ± 0.97 µmol Trolox/g of DE, 66.54 ± 3.97 µM FeSO4/g of DE, and 22.47 ± 1.92% of DPPH inhibition, respectively. Additionally, the isoflavone extracts from Thua-nao had high isoflavone contents and polyphenolic compound compositions, especially daidzein and genistein. The isoflavone demonstrated a weak inhibition of MCF-7 and HEK293 cancer cell growth. It has a high antioxidant component, which is beneficial and can be developed for new therapeutic uses. However, further studies on the benefits of Thua-nao should be performed for realizing better and more effective uses soon.